Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Español Near me My list Help
US Patient GuideUSA
Surprise me
Prescription medicine · generic available

Triamcinolone acetonide

Brand names: Kenalog-40, Triderm, Triesence, Kenalog-10, Kourzeq, Kenalog-80, Xipere, Oralone

Also sold without a prescription: Triamcinolone acetonide (over the counter) →

Drug class: Corticosteroid

The FDA’s “Established Pharmacologic Class”: the group of medicines that work in a similar way.

Full FDA label All drugs

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

At a glance

NoBoxed warning
None listedFDA shortage list
8Recalls (FDA reports)
50Companies
1960First FDA approval on file

Quick answers

What is Triamcinolone acetonide used for?
The FDA-approved label (Kenalog-10, A-S Medication Solutions, July 30, 2026) says: “The intra-articular or soft tissue administration of KENALOG-10 Injection (triamcinolone acetonide injectable suspension, USP) is indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, synovitis of osteoarthritis. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Triamcinolone acetonide have a boxed warning?
No. None of the 171 FDA labels we found for this medicine has a boxed warning.
Is there a shortage of Triamcinolone acetonide?
No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
Has Triamcinolone acetonide been recalled?
FDA enforcement reports list 8 recalls of products of this medicine; the newest started July 15, 2026 (Class III). A recall usually concerns specific lots, not every product.
Who makes Triamcinolone acetonide?
50 companies list prescription products of Triamcinolone acetonide in the FDA NDC Directory, including Bryant Ranch Prepack, A-S Medication Solutions and Proficient Rx LP.

What Triamcinolone acetonide is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

The intra-articular or soft tissue administration of KENALOG-10 Injection (triamcinolone acetonide injectable suspension, USP) is indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, synovitis of osteoarthritis. …

— FDA label: Kenalog-10, A-S Medication Solutions, effective July 30, 2026. Read the full label on DailyMed →

The FDA has 171 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Conditions named on the label

These condition names appear word for word in the label’s “Indications and Usage” text (matched with a reviewed table). Each page lists hospitals whose own websites name the condition.

Rheumatoid arthritis

Related medical specialties

Rheumatology

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

The label quoted above has no boxed warning.

0 of 171 FDA labels for this medicine have a boxed warning.

Forms and how it is given

Dosage formsCream · Ointment · Injection, suspension · Paste · Lotion · Suspension · Aerosol, spray
RouteTopical · Intramuscular · Intra-articular · Dental · Intra-arterial · Ophthalmic
Prescription products232 in the FDA NDC Directory
Brand namesKenalog-40, Triderm, Triesence, Kenalog-10, Kourzeq, Kenalog-80, Xipere, Oralone

What pharmacies pay (NADAC)

The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.

This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.

NADAC per unit for Triamcinolone acetonide, by strength and form
Strength and formGeneric or brandPharmacies pay
triamcinolone acetonide 0.0147%
aerosol, spray		 Generic $2.00–$2.72 per gram
2 packages, lowest to highest
triamcinolone acetonide 0.025%
cream		 Generic $0.0344–$0.1261 per gram
14 packages, lowest to highest
triamcinolone acetonide 0.025%
ointment		 Generic $0.0471–$0.2322 per gram
12 packages, lowest to highest
triamcinolone acetonide 0.05%
ointment		 Generic $0.1867 per gram
triamcinolone acetonide 0.1%
cream		 Generic $0.0252–$0.1042 per gram
31 packages, lowest to highest
triamcinolone acetonide 0.1%
ointment		 Generic $0.0341–$0.1215 per gram
22 packages, lowest to highest
triamcinolone acetonide 0.1%
paste		 Generic $2.46 per gram
triamcinolone acetonide 0.25 mg/mL
lotion		 Generic $0.3437 per mL
triamcinolone acetonide 0.5%
cream		 Generic $0.1886 per gram
triamcinolone acetonide 0.5%
ointment		 Generic $0.2753 per gram
triamcinolone acetonide 1 mg/mL
lotion		 Generic $0.2657 per mL
triamcinolone acetonide 10 mg/mL
injection, suspension		 Brand: Kenalog-10 $2.33 per mL
triamcinolone acetonide 200 mg/5 mL
injection, suspension		 Generic $6.36 per mL
triamcinolone acetonide 40 mg/mL
injection, suspension		 Generic $4.82–$7.45 per mL
13 packages, lowest to highest
triamcinolone acetonide 40 mg/mL
injection, suspension		 Brand: Kenalog-40 $6.79–$9.18 per mL
3 packages, lowest to highest
triamcinolone acetonide 40 mg/mL
suspension		 Generic $4.82–$6.36 per mL
3 packages, lowest to highest
triamcinolone acetonide 400 mg/10 mL
injection, suspension		 Generic $4.82 per mL
triamcinolone acetonide 80 mg/mL
injection, suspension		 Brand: Kenalog-80 $17.87 per mL

NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.

Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
Brand and biologic applications
ApplicationSponsorApprovedLater changes approved
NDA012041
KENALOG-10		 ApotheconJanuary 4, 1960 29, latest August 14, 2024
2024: Manufacturing (CMC) · 2024: Labeling · 2018: Labeling
NDA014901
KENALOG-40, KENALOG-80		 ApotheconFebruary 1, 1965 29, latest August 9, 2024
2024: Manufacturing (CMC) · 2024: Labeling · 2019: Manufacturing (CMC)
NDA022048
TRIESENCE		 Harrow EyeNovember 29, 2007 1, latest June 23, 2014
2014: Manufacturing (CMC)
NDA211950
XIPERE		 Bausch and Lomb IncOctober 22, 2021 1, latest May 22, 2025
2025: Labeling

Generic approvals (45)

Showing the 40 earliest of 45.

Shortage status

Shortage resolved · updated July 31, 2026 · first posted September 27, 2021

ProductTriesence, Injection, 40 mg/1 mL (NDC 82667-800-01)
CompanyHarrow Eye, LLC

FDA Drug Shortages database →

Recalls

From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.

  1. July 15, 2026 · Class III · Ongoing · D-0713-2026

    Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

    Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01. — Asclemed USA Inc.

  2. May 18, 2026 · Class III · Ongoing · D-0552-2026

    Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

    Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02 — Eugia US LLC

  3. September 28, 2023 · Class II · Ongoing · D-0041-2024

    Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial.

    Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per 10 mL (40mg/mL), 10 mL Multiple Dose Vial, Rx Only, For Intramuscular or Intra-articular use only, Shake Well, Not for IV/ID, intraocular, epidural, or intra — Eugia US LLC

  4. September 12, 2022 · Class II · Completed · D-1535-2022

    CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.

    Triamcinolone Acetonide cream, 0.1%, 80 g tube, Rx only, Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534, Dist. By Perrigo, Allegan, MI 49010, NDC 72189-330-80. — Direct Rx

  5. August 17, 2022 · Class II · Terminated · D-1497-2022

    CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.

    Triamcinolone Acetonide Cream USP, 0.1%, 80 g tube, Rx Only, Manufactured By Perrigo, Bronx, NY 10457, Distributed By Perrigo, Allegan, MI 49010, NDC 45802-064-36. — Padagis US LLC

  6. April 13, 2022 · Class II · Terminated · D-1106-2022

    cGMP deviations: Temperature abuse

    Triamcinolone Acetonide cream, USP, 0.1% ,15 grams tube, Rx only, MFG: Sandoz Pharma, NDC 0168-0004-15 — Mckesson Medical-Surgical Inc. Corporate Office

  7. March 15, 2021 · Class II · Terminated · D-0551-2021

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    Triamcinolone Acetonide Ointment, USP, 0.025% 80g; Rx Only, Distributed by: Perrigo, Allegan, MI 49010,NDC 45802-054-36 — Cardinal Health Inc.

  8. January 29, 2014 · Class III · Terminated · D-1152-2014

    Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%.

    Triamcinolone Acetonide Cream USP, 0.1%, Net Wt 80 grams per tube, Rx only, E. Fougera & Co., A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0004-80, UPC 3 0168-0004-80 8. — Fougera Pharmaceuticals Inc.

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Official identifiers

RxCUI (RxNorm)1014314, 1085633, 1085636, 1085640, 1085644, 1085686, 1085728, 1085736, 1085741, 1085745 … (+10)
SPL set ID of the quoted label653ec195-0966-478d-be47-6b1ff158e111
FDA labels (SPL)171
FDA applicationsNDA012041, NDA014901, NDA022048, NDA211950, 45 ANDA
Active ingredients (FDA)TRIAMCINOLONE ACETONIDE

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — Kenalog-10, A-S Medication Solutions, effective July 30, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers